Protocol to evaluate sequential electronic health record-based strategies to increase genetic testing for breast and ovarian cancer risk across diverse patient populations in gynecology practices

Germline genetic testing is recommended by the National Comprehensive Cancer Network (NCCN) for individuals including, but not limited to, those with a personal history of ovarian cancer, young-onset (

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Implementation science : IS 2023-11, Vol.18 (1), p.57-11, Article 57
Hauptverfasser:	Symecko, Heather, Schnoll, Robert, Beidas, Rinad S, Bekelman, Justin E, Blumenthal, Daniel, Bauer, Anna-Marika, Gabriel, Peter, Boisseau, Leland, Doucette, Abigail, Powers, Jacquelyn, Cappadocia, Jacqueline, McKenna, Danielle B, Richardville, Robert, Cuff, Lauren, Offer, Ryan, Clement, Elizabeth G, Buttenheim, Alison M, Asch, David A, Rendle, Katharine A, Shelton, Rachel C, Fayanju, Oluwadamilola M, Wileyto, E Paul, Plag, Martina, Ware, Sue, Shulman, Lawrence N, Nathanson, Katherine L, Domchek, Susan M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Behavioral economics Breast cancer Cohort Studies Decision making Electronic health record Electronic Health Records Female Genetic testing Genetic Testing - methods Gynecology Humans Implementation science Male Mens health Nudges Ovarian cancer Ovarian Neoplasms Pragmatic Clinical Trials as Topic Sequential Study Protocol Womens health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Germline genetic testing is recommended by the National Comprehensive Cancer Network (NCCN) for individuals including, but not limited to, those with a personal history of ovarian cancer, young-onset (
ISSN:	1748-5908 1748-5908
DOI:	10.1186/s13012-023-01308-w